Metod Miklus

Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany.

HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland.

Intendis GmbH specializes in dermatological drugs. Its products are to treat acne, rosacea, eczema, psoriasis, and fungal infections. The company operates in Austria, Brazil, France, Germany, Italy, Japan, Mexico, Poland, Portugal, Russia, Spain, Turkey, and the USA. It was founded in 2005 and is headquartered in Berlin, Germany.

BioAgency AG provides financing services. The company is headquartered in Hamburg, Germany.

Bio-Techne is a life sciences company founded in 1981 that provides innovative tools and bioactive reagents for the research and clinical diagnostic communities. The company is based in Devens, MA. The company's products aid in scientific investigations into biological processes and the nature and progress of specific diseases, drug discovery efforts, and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $1.10 billion in net sales in fiscal 2023 and has approximately 3,200 employees worldwide.

B·R·A·H·M·S GmbH engages in the development and manufacture of novel diagnostic testing procedures. Its products include B·R·A·H·M·S PCT (Procalcitonin), MR-proADM (Mid-regional proadrenomedullin), Copeptin proAVP, Neopterin, and KRYPTOR Instruments. The company was founded in 1994 and is headquartered in Hennigsdorf, Germany.

DefaqtoMedia Ltd. operates as an independent financial product and fund information and ratings agency. It specializes in comparing and analyzing financial products. The firm provides insight and consultancy to financial services sectors including IFAs, mortgage and general insurance brokers, web aggregators and the public sector. The company was founded on May 18, 1995 and is headquartered in Aylesbury, the United Kingdom.

Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany.

Vivacta Ltd. operates as a medical diagnostics company. It develop point of care diagnostic device and microfluidic cartridge. The company is founded in 2005 and is headquartered in Camberley, the United Kingdom.

Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA.

Buse Heberer Fromm Rechtsanwälte - Steuerberater PartG is a law firm based in Hamburg, Germany, with subsidiaries in Germany. Buse Heberer Fromm Rechtsanwälte - Steuerberater PartG provides legal and tax advice in all areas of business and tax law, with over 100 lawyers available to provide competent guidance. The German company was founded by Hartmut Fromm.

Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom.

Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden.

Part of HBM Partners AG, HBM Healthcare Investments (Cayman) Ltd. provides healthcare services. The private company is based in George Town, Cayman Islands. Andreas Wicki has been the CEO of the company since 2001.

iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium.

SphingoTec GmbH develops method for prediction, prevention, intervention of cancer, cardiovascular disease and kidney function. The firm specializes in biomarker discovery and acute care diagnostics. The company was founded by Andreas Bergmann in 2002 and is headquartered in Hennigsdorf, Germany.

InVivo BioTech Services GmbH engages in contract manufacturing organization dedicated to the development and production of monoclonal antibodies and expression of recombinant proteins. The company was founded by Andreas Bergmann in 1998 and is headquartered in Hennigsdorf, Germany.

4teen4 Pharmaceuticals GmbH engages in the research and development in diagnostic and therapeutics bio markets. The company was founded by Andreas Bergmann in 2013 and is headquartered in Hennigsdorf, Germany.

MS Unisea GmbH & Co. KG provides sea and coastal freight transportation services. The private company is based in Haren, Germany. The CEOs of the German company are Andreas Bergmann, Bernhard Held.

MS Unistream GmbH & Co. KG provides warehousing services. The private company is based in Haren, Germany. The CEOs of the German company are Andreas Bergmann, Bernhard Held.

Belano Medical AG is a leading German company in the development and production of innovative active substances for the human microbiome. The private company is based in Hennigsdorf, Germany. The company's focus is on microbiotic active substances and microbiome products. The CEO of the company is Bernd Wegener.

Mahzi Therapeutics is a private biotechnology company that focuses on genetic therapies for rare genetic neurodevelopmental disorders. The company was founded by Yael Weiss and is based in San Mateo, CA. The company unites patient and family groups, academic researchers, diagnostic companies, other industry members, and its internal team of experts to develop therapies for patients with these serious diseases. Mahzi's team is experienced in all aspects of biopharmaceutical research, development, and manufacturing and is driven to make a difference in the lives of patients with rare genetic diseases. Yael Weiss has been the CEO since incorporation.

PAM Theragnostics GmbH is a German biotech company that aims to develop a reliable tool for early diagnosis of Alzheimer's disease. PAM Theragnostics is based in Hennigsdorf, DE. The company's long-term vision is to provide safe and cost-effective therapy for Alzheimer's patients. Andreas Bergmann is a visionary who has launched and co-founded several successful biotech companies, including Sphingotec GmbH, 4teen4, and Adrenomed AG. The company was founded by Andreas Bergmann, who has been the CEO since incorporation.

febit holding GmbH engages in the design and development of technologies used for DNA analysis. It specializes in technologies with applications in genomic research, RNA expression profiling, and other diagnostic and molecular biology fields. The company was founded by Markus Beier, Ramon Gueimil, Peer F. Staehler, Matthias Scheffler, and Cord F. Stähler in 2005 and is headquartered in Heidelberg, Germany.

Avenit AG provides web development services. The private company is based in Offenburg, Germany. and has subsidiaries in Germany. The German company was founded in 1995 by Christian Seifert. Christian Seifert has been the CEO since 1995.